Having trouble accessing articles? Reset your cache.

FDA panel backs Merck anti-infective Zinplava

FDA's Antimicrobial Drugs Advisory Committee voted 10-5, with one abstention, that Merck & Co. Inc. (NYSE:MRK)

Read the full 167 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE